drugset / Trial / NCT00870454
An Efficacy and Safety Study of Carisbamate in the Treatment of Nerve Pain in Diabetics
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, and efficacy of carisbamate (800 and 1200 mg/day) in patients with diabetic neuropathic pain.
Timeline
- Start
- 2009-05
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carisbamate | Small molecule | 800 mg | Oral |
| Subject | Carisbamate | Small molecule | 1200 mg | Oral |
| Comparator | Pregabalin | Small molecule | 300 mg | Oral |